| Title |
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, July 2011
|
| DOI | 10.2147/ndt.s22635 |
| Pubmed ID | |
| Authors |
Tiffany W Chow, Ariel Graff-Guerrero, Nicolaas PLG Verhoeff, Malcolm A Binns, David F Tang-Wai, Morris Freedman, Mario Masellis, Sandra E Black, Alan A Wilson, Sylvain Houle, Bruce G Pollock |
| Abstract |
Memantine has shown effects on cortical metabolism in Alzheimer's disease (AD), and the mechanism of action may not be specific to AD alone. We hypothesized that participants with frontotemporal dementia taking memantine would show an increased cortical metabolic activity in frontal regions, temporal regions, or in salience network hubs. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Germany | 1 | 1% |
| Unknown | 95 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 18% |
| Student > Master | 13 | 13% |
| Other | 12 | 12% |
| Student > Bachelor | 11 | 11% |
| Student > Ph. D. Student | 9 | 9% |
| Other | 20 | 20% |
| Unknown | 15 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 28% |
| Psychology | 20 | 20% |
| Agricultural and Biological Sciences | 6 | 6% |
| Nursing and Health Professions | 5 | 5% |
| Neuroscience | 5 | 5% |
| Other | 10 | 10% |
| Unknown | 25 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2017.
All research outputs
#16,047,334
of 25,374,647 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,583
of 3,132 outputs
Outputs of similar age
#88,948
of 127,143 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#8
of 12 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,143 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.